argenx NV ADR (ARGX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $60.37B
Last updated: Nov 17, 2026 at 11:04 AM ET
argenx NV ADR (ARGX) Competitors
The companies most similar to argenx NV ADR are BeOne Medicines AG (ONC), Genmab AS (GMAB) and Regeneron Pharmaceuticals (REGN). argenx NV ADR trades at 33.5x earnings, against a median of 24.7x for the 6 of these companies with a P/E. By market cap, argenx NV ADR ranks 4th of the 13 companies on this page; Vertex Pharmaceuticals (VRTX) is the largest at $136.56B.
Peer Comparison
ARGX's revenue growth of 52.1% is above the peer median of 22.6%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| argenx NV ADR (ARGX) | $60.37B | 33.5x | 6.1x | 31.7% | N/A | 52.1% | 0.00% |
| BeOne Medicines AG (ONC) | $47.58B | 50.0x | 18.7x | 13.9% | 7.5% | 33.8% | 0.00% |
| Genmab AS (GMAB) | $31.67B | 35.8x | 19.2x | 17.0% | 4.8% | 16.1% | 0.00% |
| Regeneron Pharmaceuticals Inc (REGN) | $98.84B | 18.4x | 5.7x | 28.5% | 13.7% | 36.3% | 0.39% |
| Moderna Inc (MRNA) | $90.38B | N/A | 34.2x | -110.5% | -28.9% | 29.2% | 0.00% |
| Revolution Medicines Inc (RVMD) | $37.27B | N/A | 181.6x | 0.0% | -52.1% | -95.2% | 0.00% |
| Insmed Inc (INSM) | $26.58B | N/A | 17.7x | -39.9% | -44.2% | 268.4% | 0.00% |
| Royalty Pharma Plc (RPRX) | $39.85B | 12.9x | 11.7x | 25.7% | 7.6% | 13.3% | 1.37% |
| Roivant Sciences Ltd (ROIV) | $28.64B | N/A | 679.3x | 0.0% | N/A | 2136.0% | 0.00% |
| Ascendis Pharma AS (ASND) | $18.06B | N/A | 13.5x | 72.9% | 12.4% | 73.0% | 0.00% |
| Exelixis Inc (EXEL) | $16.84B | 19.3x | 6.9x | 35.4% | N/A | 10.2% | 0.00% |
| Vertex Pharmaceuticals Inc (VRTX) | $136.56B | 30.0x | 10.5x | 30.7% | 14.2% | 11.8% | 0.00% |
| Apogee Therapeutics, Inc. Common Stock (APGE) | $10.22B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $34.47B | 24.7x | 17.7x | 15.4% | 7.5% | 22.6% | 0.00% |
Similar Companies
These are the 12 companies most similar to argenx NV ADR, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| BeOne Medicines AG (ONC) | BeiGene, Ltd., an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe... | ONC competitors |
| Genmab AS (GMAB) | Genmab A / S develops antibody therapies for the treatment of cancer and other diseases mainly in Denmark. The company is headquartered in Copenhagen, Denmark. | GMAB competitors |
| Regeneron Pharmaceuticals Inc (REGN) | Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. | REGN competitors |
| Moderna Inc (MRNA) | Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology... | MRNA competitors |
| Revolution Medicines Inc (RVMD) | Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted... | RVMD competitors |
| Insmed Inc (INSM) | Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. | INSM competitors |
| Royalty Pharma Plc (RPRX) | Royalty Pharma plc is a buyer of biopharmaceutical royalties and funder of innovations in the biopharmaceutical industry in the United States. | RPRX competitors |
| Roivant Sciences Ltd (ROIV) | Roivant Sciences Ltd (ROIV) is a transformative biopharmaceutical company focused on advancing drug development and commercialization through a distinctive... | ROIV competitors |
| Ascendis Pharma AS (ASND) | Ascendis Pharma A / S, a biopharmaceutical company, develops therapies for unmet medical needs. The company is headquartered in Hellerup, Denmark. | ASND competitors |
| Exelixis Inc (EXEL) | Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development... | EXEL competitors |
| Vertex Pharmaceuticals Inc (VRTX) | Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts. | VRTX competitors |
| Apogee Therapeutics, Inc. Common Stock (APGE) | Apogee Therapeutics, Inc., through its subsidiary, is a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD)... |
Frequently Asked Questions About ARGX
Who are argenx NV ADR's main competitors?
The companies most similar to argenx NV ADR include BeOne Medicines AG (ONC), Genmab AS (GMAB), Regeneron Pharmaceuticals (REGN), Moderna (MRNA) and Revolution Medicines (RVMD), listed from the closest match.
Who is argenx NV ADR's biggest competitor?
Vertex Pharmaceuticals (VRTX) is the largest of the similar companies at $136.56B; BeOne Medicines AG (ONC) is the closest match by business profile, size, sector and industry.
How does ARGX stock compare with its competitors?
ARGX's P/E is 33.5x against a peer median of 24.7x; its P/S is 6.1x against a peer median of 17.7x; its net margin is 31.7% against a peer median of 15.4%.
Which of argenx NV ADR's competitors pays a higher dividend?
argenx NV ADR pays no dividend. Royalty Pharma Plc (RPRX) and Regeneron Pharmaceuticals (REGN) have higher forward dividend yields; Royalty Pharma Plc (RPRX) has the highest at 1.37%.
Is argenx NV ADR bigger than its competitors?
No. argenx NV ADR is 4th by market cap among the 13 companies on this page; the largest is Vertex Pharmaceuticals (VRTX) at $136.56B.
ARGX pages: Overview, Valuation, Competitors